https://doi.org/10.4081/bse.97
Renewing potency assays: Moving forward from traditional methods
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Merck is global market leader in the fertility and growth hormone deficiency treatment. The quality control analytical panels for each new produced batch envisage the potency quantification that is estimated using a dedicated in vivo assay. Indeed, no in vitro methods for gonadotropin potency quantification are available in any pharmacopoeia. Merck Ivrea started a project to replace the in vivo assays with in vitro assays able to mimic the physiological mechanism of action of each gonadotropin and growth hormone.
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Similar Articles
- Flaminia Aliberti, Lorenza Rinvenuto, Giada Loi, Laura Benedetti, Franca Scocozza, Flavio Lorenzo Ronzoni, Maurilio Sampaolesi, Gabriella Cusella, Michele Conti, Gabriele Ceccarelli, Comparative analysis of different hydrogels for the bioprinting of 3D in vitro skeletal muscle models , Biomedical Science and Engineering: Vol. 2 No. 1 (2021)
- Claudio Conci, Emanuela Jacchetti, Tommaso Zandrini, Laura Sironi, Maddalena Collini, Giuseppe Chirico, Giulio Cerullo, Roberto Osellame, Manuela Teresa Raimondi, Quantification of the foreign body reaction by means of a miniaturized imaging window for intravital nonlinear microscopy , Biomedical Science and Engineering: Vol. 1 No. 1 (2020)
You may also start an advanced similarity search for this article.
